Hollab header picture_2_2000x700
previous arrow
next arrow

Translational Neuroscience

The research mission of the Department of Translational Neuroscience is to discover and delineate mechanisms and processes which are fundamental to the development of neural systems and to the control of behavior as well as to translate these to pathogenesis and disease models. We use cutting edge technology, disease models as well as computational tools to achieve these goals.

Our teaching mission is to raise the next generation scientists and clinicians with state-of-the-art knowledge, technical expertise and vision in the field of neuroscience. As a part of this effort, we teach in several Bachelor courses, coordinate the Neuroscience and Cognition master program of the Utrecht University and offer doctoral and postdoctoral training.

News

October 29, 2026 / Meeting, News

Shapeshifters Symposium: Plasticity – Here, There, and Everywhere

The Plasticity consortium, a group of interdisciplinary researchers led by the Translation Neuroscience faculty member Onur Başak, PhD, would like to invite you to join and contribute to the 2nd Shapeshifters Symposium: Plasticity – Here, There, and Everywhere.

This Shapeshifters Symposium brings together people interested in plasticity from a broad range of perspectives, from the natural and formal sciences to the social sciences, humanities, and art. During the symposium, we hope to further expand the concept of plasticity across disciplines.

Who are we? We are a group of interdisciplinary researchers working on the concept of plasticity, sponsored by the Dutch Centre for Unusual Collaborations.

Date & Venue
19th – 21st November 2026, Utrecht, The Netherlands
Day 1: Museum Speelkok
Day 2 & 3: Utrecht University Museum

Keynote speakers
Zakkiyah Iman Jackson – Department of Literature, Duke University, North Carolina, USA
Suparna Choudhury – Department of Applied Human Sciences, Concordia University, Canada
Heleen Slagter – Department of Applied and Experimental Psychology, Vrije Universiteit Amsterdam
Maurizio Meloni – School of Humanities and Social Sciences, Deakin University, Australia

Registration
Please register via this form by Friday 13th November: https://tally.so/r/QKlyxk
Students, staff and independent researchers are welcome to join.

See our poster or the website for a full program.

Shapeshifters Symposium poster

This project is funded by the CuCo unusual collaborations grant, organised by the Ewuu alliance.

May 19, 2025 / Grants, News

New Woelse Waard grant for Elly Hol: reactive gliosis in Parkinson’s Disease

PI Elly Hol with PhD student Hanne Twenhöfel
PI Jeroen Pasterkamp
PI Frank Meye

 

 

 

 

 

 

 

Unravelling the role of glial cells in brain disease

Glial cells are crucial for brain function, providing essential support to neurons, yet they remain understudied in the context of brain diseases. When an inflammatory response known as ‘reactive gliosis’ occurs, these cells may lose their neuron-supportive functions and contribute to disease onset. A research team from UMC Utrecht, led by Professor Elly Hol, has secured a Woelse Waard grant to study glial cells in the context of Parkinson’s Disease.

Parkinson’s Disease (PD) is a neurodegenerative brain disease in which midbrain dopaminergic neurons, necessary for coordinating movement, gradually degenerate. The new research project, dubbed ‘GliaPark’, strives to uncover how glia are involved. This is a crucial stepping stone to developing therapeutics to halt this neurodegenerative process and utilizing glial cells as a new target in PD and other brain diseases.

Targeting astrocytes

One specific type of glial cell is the astrocyte. In PD, astrocytes have been significantly less researched than dopaminergic neurons. Elly Hol, professor of Glia biology of brain diseases, explains: “Astrocytes are known to undergo reactive gliosis in PD. The change in astrocytes will contribute to neurodegeneration and can lead to an early loss of dopaminergic neurons. Therefore, targeting astrocytes might help to prevent neuron loss.”

Organoids

The new study is spearheaded by Elly Hol. She will carry out the project together with Translational Neuroscience researchers Jeroen Pasterkamp, Frank Meye, and PhD student Hanne Twenhöfel, alongside a patient researcher from the Parkinson’s Association. The team will use in vitro models derived from Parkinson’s patients to examine how these cells behave under reactive gliosis conditions, aiming to shed new light on neurodegenerative mechanisms and potential therapeutic strategies.

To achieve this, the researchers will create 2D and 3D co-culture models using human induced pluripotent stem cell (iPSC)-derived dopaminergic neurons and astrocytes, incorporating varying PD mutations. They will then assess differences in cell activity, reactive gliosis, morphology, neuropathology, and RNA expression across these cultures and controls.

Deeper insights

Ultimately, the researchers want to create assembloids: interconnected midbrain and striatum organoids (implementing a protocol by Jürgen Knoblich). The midbrain is normally connected to the striatum, providing dopaminergic input for movement control. In PD, when midbrain dopaminergic neurons degenerate, the striatum loses that input. With these assembloids, the team can investigate how a PD midbrain organoid affects a control striatum organoid, and vice versa, to gain deeper insights into neurodegenerative processes.

Follow-up project

In the next few years, Elly plans to initiate a follow-up project to expand upon the results found and, wherever possible, to conduct valorization by working together with a company on possible further development of medication targeting astrocytes. By uncovering how astrocytes contribute to neurodegeneration, these studies could lay the groundwork for new therapies for PD and potentially other brain diseases.

Consortia

Among the researchers, there are strong interactions with the following consortium projects: the BrainScapes program (gravity subsidy – dopaminergic system), spanning the VU, Amsterdam UMC, LUMC, and TU Delft; and MODEM (dementia program ZonMW – neuron-glia interactions), spanning the VU, Amsterdam UMC, LUMC, TU Delft, Radboud UMC, UMCG, and MUMC.

Vrienden UMC Utrecht & Wilhelmina Kinderziekenhuis

This research project is made possible thanks to the support granted by Stichting Woelse Waard to Stichting Vrienden UMC Utrecht & Wilhelmina Children’s Hospital, the charity of the (children’s) hospital. If you would like to contribute to our research, please contact Stichting Vrienden by phone at 088 756 10 10, or go to https://vriendenumcutrecht-wkz.nl/.

April 9, 2025 / News, Research paper

Reward and Stress is orchestrated by small ensembles of neurons in the midbrain.

A. The VTA is comprised of different neurotransmitter-defined neuronal subtypes. B. Distinct, non-overlapping ensembles composed of these different neuronal subtypes were activated for positive valence experiences vs. negative valence experiences.

How do small groups of neurons decide whether we approach a reward or avoid a threat? In a study published April 2nd 2025 in Nature Communications, Frank Meye’s lab at UMC Utrecht shows that distinct neuronal clusters (i.e. neuronal ensembles) in the ventral tegmental area (VTA) are essential for encoding positive and negative experiences.

First author Ioannis Koutlas and colleagues used an innovative approach in transgenic mice where they tagged neurons in the VTA which, based on immediate early gene expression, had become active in response to a particular environmental stimulus. They first established that acute exposure to a rewarding opioid or to a stressful social confrontation triggered opposite behavioral outcomes (approach vs avoidance). They then showed that these two distinct experiences tagged two largely non-overlapping ensembles of neurons in the VTA. These sets were of approximately similar small size (10% of VTA neurons). Moreover, each ensemble comprised multiple neurotransmitter-defined neuronal cell types, and the compositions thereof were similar between the ensembles. This indicates that neurotransmitter-based identities are not sufficient to parse neurons in functional terms.

The researchers then stimulated or inhibited these small ensembles to assess their role in behavior. By selectively activating these groups with opto- or chemogenetics, the researchers drove strong reward-seeking (reward ensemble) or avoidance responses (stress ensemble). Instead, targeted inhibition of these small ensembles fully blocked adaptive behaviors such as stress-driven avoidance, and reward-driven approach behaviors. These experiments identify the crucial role of VTA ensembles of specific cell types in processes of aversion and reward.

An operant task, in which the mouse can choose to optogenetically stimulate the positive valence ensemble by poking its nose into the active port.
Immunohistochemical staining shows the expression of TH, CoChR-GFP, and 2 implanted fiber optic cannulae in the VTA, which can optogenetically stimulate selectively tagged ensembles.

Perturbations in processing such valence processes are a fundamental problem in various brain disorders, not only including psychiatric conditions such as eating disorders, drug addiction and depression, but also neurological disorders like dementia and Parkinson’s disease. The results from this study are therefore an important stepping stone towards understanding, with further research, which exact neuronal cell types contribute to pervasive aversion/reward problems across brain diseases. 

 

 

 

“Our findings shed light on the organization of the VTA into valence-specific ensembles, which is key to orchestrating adaptive behavioral responses,” says first author Ioannis Koutlas.

The work was carried out at the Translational Neuroscience Department at the UMC Utrecht Brain Center. Please read the full publication here.

Vacancies

We welcome open applications from PhD candidates and postdocs.

WP Twitter Auto Publish Powered By : XYZScripts.com